Publication | Closed Access

Genetic polymorphisms in the mevalonate pathway affect the therapeutic response to alendronate treatment in postmenopausal Chinese women with low bone mineral density

Bone DiseaseBone HealthGenetic PolymorphismsGeneticsMevalonate PathwayTherapeutic ResponseMedicineOsteoporosisBone MetabolismWomen's Health